Thermo Fisher Scientific Reports Third Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.32, Revenues Beat
October 21, 2020 6:02 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.63, $1.32 better than the analyst estimate of $4.31. Revenue for the quarter came in at $8.52 billion versus the consensus estimate of $7.65 billion.
Third Quarter 2020 Highlights
Third quarter revenue increased 36% to $8.52 billion.Third quarter GAAP diluted earnings per share (EPS) increased 157% to $4.84.Third quarter adjusted EPS increased 91% to $5.63.Generated $2.0 billion of COVID-19 related revenue in the quarter and returned the base business to growth.Further expanded our global pandemic response, including launching the Amplitude Solution to automate high-throughput PCR-based testing, adding... More